An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
Open accessThe DOI matches its Crossref record; 324 of the 325 references it cites were found in a registry or an index.
Abstract
This document is an international evidence-based guideline on the diagnosis and management of idiopathic pulmonary fibrosis, and is a collaborative effort of the American Thoracic Society, the European Respiratory Society, the Japanese Respiratory Society, and the Latin American Thoracic Association. It represents the current state of knowledge regarding idiopathic pulmonary fibrosis (IPF), and contains sections on definition and epidemiology, risk factors, diagnosis, natural history, staging and prognosis, treatment, and monitoring disease course. For the diagnosis and treatment sections, pragmatic GRADE evidence-based methodology was applied in a question-based format. For each diagnosis and treatment question, the committee graded the quality of the evidence available (high, moderate, low, or very low), and made a recommendation (yes or no, strong or weak). Recommendations were based on majority vote. It is emphasized that clinicians must spend adequate time with patients to discuss patients' values and preferences and decide on the appropriate course of action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, all patients originally gathered from hospital register using ICD-10 codes were meticulously re-assessed and re-classified using the year 2011 criteria, and the cases representing some other type of ILDs were excluded [14].”
From Comparison of disease progression subgroups in idiopathic pulmonary fibrosis (2019) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“ILD still has a poor prognosis and the highest mortality rate during lung transplantation.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [48]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interstitial lung disease (ILD) remains an important indication for lung transplantation, and the number of patients with this disease is increasing.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [48]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Idiopathic pulmonary fibrosis (IPF), characterized histopathologically and/or radiologically with a usual interstitial pneumonia (UIP) pattern, is the most common adult form of interstitial pneumonia of unknown origin [1].”
From Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature (2014) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The median survival time for patients with IPF is 2 to 3 years from diagnosis and the 5-year survival rate ranges between 30% and 50% [1,5-7].”
From Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature (2014) · cites this paper as [1]
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Miller, M. R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Crapo, R., Enright, P., van der Grinten, C. P. M., Gustafsson, P., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00034805 · Cited by 15,627
ATS Statement: Guidelines for the Six-Minute Walk Test
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.166.1.at1102 · Cited by 11,195
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
Interpretative strategies for lung function tests
Pellegrino, R., Viegi, G., Brusasco, V., Crapo, R. O., Burgos, F., Casaburi, R., Coates, A., van der Grinten, C. P. M., Gustafsson, P., Hankinson, J., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00035205 · Cited by 5,945
Fleischner Society: Glossary of Terms for Thoracic Imaging
Hansell, D. M., Bankier, A. A., MacMahon, H., McLoud, T. C., Müller, N. L., & Remy, J. (2008) · Radiology · doi:10.1148/radiol.2462070712 · Cited by 4,198
Self-citation(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Standardisation of the measurement of lung volumes
Wanger, J., Clausen, J. L., Coates, A., Pedersen, O. F., Brusasco, V., Burgos, F., Casaburi, R., Crapo, R., Enright, P., van der Grinten, C. P. M., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00035005 · Cited by 2,768
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
Standardisation of the single-breath determination of carbon monoxide uptake in the lung
MacIntyre, N., Crapo, R. O., Viegi, G., Johnson, D. C., van der Grinten, C. P. M., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Enright, P., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00034905 · Cited by 2,255
NOCTURNAL OXYGEN THERAPY TRIAL GROUP* (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-3-391 · Cited by 2,218
Research works printed but not linked: 9
- Cochrane Handbook for Systematic Reviews of Interventions 5.0.2. Oxford: The Cochrane Collaboration, 2009. [online] 2009. [accessed 20 June 2010]; Available from: http://www.cochrane.org/resources/handbook/.
- Nadrous HF, Ryu JH, Douglas WW, Decker PA, Olson EJ. Impact of angiotensin-converting enzyme inhibitors and statins on survival in idiopathic pulmonary fibrosis. Chest 2004;126:438–446. [DOI] [PubMed] [Google Scholar]
- 2005, J Gastrointest Surg, 1053
- Marshall RP, Puddicombe A, Cookson WO, Laurent GJ. Adult familial cryptogenic fibrosing alveolitis in the UK. Thorax 2000;55:143–146. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med 2001;345:517–525. [DOI] [PubMed] [Google Scholar]
- Kondo A, Saiki S. Acute exacerbation in idiopathic interstitial pneumonia (IIP). In: Harasawa M, Fukuchi Y, Morinari H, editors. Interstitial pneumonia of unknown etiology. Tokyo: University of Tokyo Press; 1989. pp. 33–42.
- Flaherty KR, Colby TV, Toews GB, Travis WD, Flint A, Gay SE, Strawderman RL III, Jain A, Lynch JP III, Martinez FJ. Differential presence of fibroblastic foci in UIP patients with or without conntective tissue disease. Am J Respir Crit Care Med 2001;163:A983. [Google Scholar]
- Molina-Molina M, Badia JR, Marin-Arguedas A, Xaubet A, Santos MJ, Nicolas JM, Ferrer M, Torres A. Outcomes and clinical characteristics of patients with pulmonary fibrosis and respiratory failure admitted to an intensive care unit: a study of 20 cases. Med Clin (Barc) 2003;121:63–67. [DOI] [PubMed] [Google Scholar]
- Pitsiou G, Ioannis Trigonis I, Tsiata E, Kontou P, Manolakoglou N, Stanopoulos I, Mavrofridis E, Argyropoulou P. Outcome of patients with pulmonary fibrosis admitted to the ICU for acute respiratory failure. Eur Respir J Suppl 2006;28:E650. [Google Scholar]
Cited by
Items 501–600 of 1,060
Genetics in Idiopathic Pulmonary Fibrosis Pathogenesis, Prognosis, and Treatment
Kaur, A., Mathai, S. K., & Schwartz, D. A. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00154 · Cited by 129
Tissue remodelling in pulmonary fibrosis
Knudsen, L., Ruppert, C., & Ochs, M. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2543-2 · Cited by 129
Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis
Katô, E., Takayanagi, N., Takaku, Y., Kagiyama, N., Kanauchi, T., Ishiguro, T., & Sugita, Y. (2018) · ERJ Open Research · doi:10.1183/23120541.00111-2016 · Cited by 129
Kalchiem‐Dekel, O., Galvin, J. R., BURKE, A. P., Atamas, S. P., & Todd, N. W. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7120476 · Cited by 129
Pulmonary hypertension in chronic interstitial lung diseases
Caminati, A., Cassandro, R., & Harari, S. A. (2013) · European Respiratory Review · doi:10.1183/09059180.00002713 · Cited by 129
Management of Myositis-Related Interstitial Lung Disease
Morisset, J., Johnson, C. R., Rich, E., Collard, H. R., & Lee, J. S. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.04.007 · Cited by 129
Self-citationOltmanns, U., Kahn, N., Palmowski, K., Träger, A., Wenz, H., Heussel, C. P., Schnabel, P. A., Puderbach, M., Wiebel, M., Ehlers-Tenenbaum, S., et al. (2014) · Respiration · doi:10.1159/000363064 · Cited by 128
Allenbach, Y., Guiguet, M., Rigolet, A., Marié, I., HACHULLA, E., Drouot, L., Jouen, F., Jacquot, S., Mariampillai, K., Musset, L., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133702 · Cited by 128
Citrullinated vimentin mediates development and progression of lung fibrosis
Li, F. J., Surolia, R., Li, H., Wang, Z., Liu, G., Kulkarni, T., Massicano, A. V. F., Mobley, J. A., Mondal, S., de Andrade, J. A., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aba2927 · Cited by 128
Lung cancer is also a hereditary disease
Benusiglio, P. R., Fallet, V., Sanchis-Borja, M., Coulet, F., & Cadranel, J. L. (2021) · European Respiratory Review · doi:10.1183/16000617.0045-2021 · Cited by 127
Matrix Remodeling in Pulmonary Fibrosis and Emphysema
Kulkarni, T., O’Reilly, P., Antony, V. B., Gaggar, A., & Thannickal, V. J. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2015-0166ps · Cited by 127
Brownell, R., Moua, T., Henry, T. S., Elicker, B. M., White, D., Vittinghoff, E., Jones, K. D., Urisman, A., Aravena, C., Johannson, K. A., et al. (2017) · Thorax · doi:10.1136/thoraxjnl-2016-209671 · Cited by 127
Self-citationRadiologic–pathologic discordance in biopsy-proven usual interstitial pneumonia
Yagihashi, K., Huckleberry, J., Colby, T. V., Tazelaar, H. D., Zach, J., Sundaram, B., Pipavath, S., Schwarz, M. I., & Lynch, D. A. (2016) · European Respiratory Journal · doi:10.1183/13993003.01680-2015 · Cited by 127
Self-citationPrognostic value of serial serum KL-6 measurements in patients with idiopathic pulmonary fibrosis
Wakamatsu, K., Nagata, N., Kumazoe, H., Oda, K., Ishimoto, H., Yoshimi, M., Takata, S., Hamada, M., Koreeda, Y., Takakura, K., et al. (2016) · Respiratory Investigation · doi:10.1016/j.resinv.2016.09.003 · Cited by 127
Prognosis of idiopathic pulmonary fibrosis without anti-fibrotic therapy: a systematic review
Khor, Y. H., Ng, Y., Barnes, H., Goh, N. S. L., McDonald, C. F., & Holland, A. E. (2020) · European Respiratory Review · doi:10.1183/16000617.0158-2019 · Cited by 127
MicroRNAs as potential targets for progressive pulmonary fibrosis
Rajasekaran, S., Rajaguru, P., & Paramasivam, S. G. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00254 · Cited by 127
Functional and prognostic effects when emphysema complicates idiopathic pulmonary fibrosis
Jacob, J., Bartholmai, B. J., Rajagopalan, S., Kokosi, M. A., Maher, T. M., Nair, A., Karwoski, R. A., Renzoni, E. A., Walsh, S. L. F., Hansell, D. M., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00379-2017 · Cited by 127
Self-citationCottin, V., & Maher, T. (2015) · European Respiratory Review · doi:10.1183/09059180.00011514 · Cited by 126
Inomata, M., Kamio, K., Azuma, A., Matsuda, K., Kokuho, N., Miura, Y., Hayashi, H., Nei, T., Fujita, K., Saito, Y., et al. (2014) · Respiratory Research · doi:10.1186/1465-9921-15-16 · Cited by 126
Vainshelboim, B., de Oliveira, J. J. F., Fox, B. D., Soreck, Y., Fruchter, O., & Kramer, M. R. (2015) · Lung · doi:10.1007/s00408-015-9703-0 · Cited by 126
Overlap of Genetic Risk between Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis
Hobbs, B. D., Putman, R. K., Araki, T., Nishino, M., Guðmundsson, G., Gudnason, V. G., Eiríksdóttir, G., Zilhäo, N. R., Dupuis, J., Xu, H., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201903-0511oc · Cited by 126
Bueno, M., Brands, J., Voltz, L., Fiedler, K., Mays, B. G., Croix, C. M. S., Sembrat, J., Mallampalli, R. K., Rojas, M. M., & Mora, A. L. (2018) · Aging Cell · doi:10.1111/acel.12720 · Cited by 126
Pirfenidone: A Review of Its Use in Idiopathic Pulmonary Fibrosis
Kim, E. S., & Keating, G. M. (2015) · Drugs · doi:10.1007/s40265-015-0350-9 · Cited by 126
Han, Q., Luo, Q., Xie, J., Wu, L., Liao, L.-Y., Zhang, X., & Chen, R. (2015) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.12.057 · Cited by 126
Idiopathic non‐specific interstitial pneumonia
Belloli, E. A., Beckford, R., Hadley, R. J., & Flaherty, K. R. (2015) · Respirology · doi:10.1111/resp.12674 · Cited by 126
Self-citationYunt, Z. X., Chung, J. H., Hobbs, S., Pérez, E. R. F., Olson, A. L., Huie, T. J., Keith, R. C., Janssen, W. J., Goldstein, B. L., Lynch, D. A., et al. (2017) · Respiratory Medicine · doi:10.1016/j.rmed.2017.03.027 · Cited by 126
Self-citationKagiyama, N., Takayanagi, N., Kanauchi, T., Ishiguro, T., Yanagisawa, T., & Sugita, Y. (2015) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2014-000058 · Cited by 126
JNK inhibition reduces lung remodeling and pulmonary fibrotic systemic markers
van der Velden, J. L. J., Ye, Y., Nolin, J. D., Hoffman, S. M., Chapman, D. G., Lahue, K. G., Abdalla, S., Chen, P., Liu, Y., Bennett, B., et al. (2016) · Clinical and Translational Medicine · doi:10.1186/s40169-016-0117-2 · Cited by 125
Ley, B., Torgerson, D. G., Oldham, J. M., Adegunsoye, A., Liu, S., Li, J., Elicker, B. M., Henry, T. S., Golden, J. A., Jones, K. D., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201902-0360oc · Cited by 125
Molecular Mechanisms in Progressive Idiopathic Pulmonary Fibrosis
Steele, M. P., & Schwartz, D. A. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-042711-142004 · Cited by 125
West Japan Oncology Group, Iwata, T., Yoshino, I., Yoshida, S., Ikeda, N., Tsuboi, M., Asato, Y., Katakami, N., Sakamoto, K., Yamashita, Y., et al. (2016) · Respiratory Research · doi:10.1186/s12931-016-0398-4 · Cited by 125
Kreuter, M., Swigris, J., Pittrow, D., Geier, S., Klotsche, J., Prasse, A., Wirtz, H., Koschel, D., Andreas, S., Claussen, M., et al. (2019) · Respiratory Research · doi:10.1186/s12931-019-1020-3 · Cited by 125
Self-citationThe Burden of Illness of Idiopathic Pulmonary Fibrosis: A Comprehensive Evidence Review
Diamantopoulos, A., Wright, E., Vlahopoulou, K., Cornic, L., Schoof, N., & Maher, T. M. (2018) · PharmacoEconomics · doi:10.1007/s40273-018-0631-8 · Cited by 125
Khanna, D., Lescoat, A., Roofeh, D., Bernstein, E. J., Kazerooni, E. A., Roth, M. D., Martínez, F. J., Flaherty, K. R., & Denton, C. P. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41933 · Cited by 125
Self-citationSalisbury, M. L., Xia, M., Zhou, Y., Murray, S., Tayob, N., Brown, K. K., Wells, A. U., Schmidt, S. L., Martínez, F. J., & Flaherty, K. R. (2015) · CHEST Journal · doi:10.1378/chest.15-0530 · Cited by 124
Self-citationHealth-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis
Yount, S., Beaumont, J. L., Chen, S., Kaiser, K., Wortman, K., Brunt, D. L. V., Swigris, J. J., & Cella, D. F. (2016) · Lung · doi:10.1007/s00408-016-9850-y · Cited by 124
Self-citationDiscovery of CC-930, an orally active anti-fibrotic JNK inhibitor
Krenitsky, V. P., Nadolny, L., Delgado, M., Ayala, L., Clareen, S. S., Hilgraf, R., Albers, R., Hegde, S. G., D’Sidocky, N., Sapienza, J., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.12.027 · Cited by 124
Optimizing quality of life in patients with idiopathic pulmonary fibrosis
van Manen, M. J. G., Geelhoed, J. J. M., Tak, N. C., & Wijsenbeek, M. S. (2017) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465816686743 · Cited by 124
Alveolar Derecruitment and Collapse Induration as Crucial Mechanisms in Lung Injury and Fibrosis
Lutz, D., Gazdhar, A., López-Rodríguez, E., Ruppert, C., Mahavadi, P., Günther, A., Klepetko, W., Bates, J. H. T., Smith, B. J., Geiser, T., et al. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2014-0078oc · Cited by 124
Role of imaging in progressive-fibrosing interstitial lung diseases
Walsh, S. L. F., Devaraj, A., Enghelmayer, J. I., Kishi, K., Silva, R. S., Patel, N. M., Rossman, M. D., Valenzuela, C., & Vancheri, C. (2018) · European Respiratory Review · doi:10.1183/16000617.0073-2018 · Cited by 124
Clinical impact of depression and anxiety in patients with idiopathic pulmonary fibrosis
Lee, Y. J., Choi, S. M., Lee, Y. J., Cho, Y., Yoon, H. I., Lee, J. H., Lee, C.-T., & Park, J. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184300 · Cited by 124
Nuovo, G. J., Hagood, J. S., Magro, C. M., Chin, N., Kapil, R., Davis, L., Marsh, C. B., & Folcik, V. A. (2012) · Modern Pathology · doi:10.1038/modpathol.2011.166 · Cited by 123
Kim, S., Herazo-Maya, J. D., Kang, D. D., Juan-Guardela, B. M., Tedrow, J., Martinez, F. J., Sciurba, F. C., Tseng, G. C., & Kaminski, N. (2015) · BMC Genomics · doi:10.1186/s12864-015-2170-4 · Cited by 123
Role of iron in the pathogenesis of respiratory disease
Ali, M. K., Kim, R., Karim, R., Mayall, J., Martin, K. L., Shahandeh, A., Abbasian, F., Starkey, M. R., Loustaud-Ratti, V., Johnstone, D. M., et al. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.05.003 · Cited by 123
Robinson, C. M., Neary, R., Levendale, A., Watson, C. J., & Baugh, J. A. (2012) · Respiratory Research · doi:10.1186/1465-9921-13-74 · Cited by 123
Clinical impact of the interstitial lung disease multidisciplinary service
Jo, H. E., Glaspole, I., Levin, K., McCormack, S. R., Mahar, A. M., Cooper, W. A., Cameron, R., Ellis, S. J., Cottee, A. M., Webster, S. E., et al. (2016) · Respirology · doi:10.1111/resp.12850 · Cited by 123
section, I., Žůrková, M., IPF registry, Kriegová, E., Kolek, V., Lošťáková, V., Šterclová, M., Bartoš, V., Doubková, M., Binková, I., et al. (2019) · Respiratory Research · doi:10.1186/s12931-019-0977-2 · Cited by 123
Demographics and survival of patients with idiopathic pulmonary fibrosis in the FinnishIPF registry
Kaunisto, J., Salomaa, E.-R. M., Hodgson, U., Kaarteenaho, R. L., Kankaanranta, H., Koli, K. M., Vahlberg, T. J., & Myllärniemi, M. (2019) · ERJ Open Research · doi:10.1183/23120541.00170-2018 · Cited by 123
Tanner, L., Single, A., Bhongir, R. K. V., Heusel, M., Mohanty, T., Karlsson, C. A. Q., Pan, L., Clausson, C.-M., Bergwik, J., Wang, K., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36314-5 · Cited by 123
Elmaleh-Sachs, A., Balte, P., Oelsner, E. C., Allen, N. B., Baugh, A. D., Bertoni, A. G., Hankinson, J., Pankow, J. S., Post, W. S., Schwartz, J. E., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202107-1612oc · Cited by 123
Akram, K. M., Samad, S., Spiteri, M. A., & Forsyth, N. R. (2013) · Respiratory Research · doi:10.1186/1465-9921-14-9 · Cited by 122
Telomere Length in Interstitial Lung Diseases
Snetselaar, R., van Moorsel, C. H. M., Kazemier, K. M., van der Vis, J. J., Zanen, P., van Oosterhout, M. F. M., & Grutters, J. C. (2015) · CHEST Journal · doi:10.1378/chest.14-3078 · Cited by 122
Heterogeneity in Unclassifiable Interstitial Lung Disease. A Systematic Review and Meta-Analysis
Guler, S. A., Ellison, K., Algamdi, M., Collard, H. R., & Ryerson, C. J. (2018) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201801-067oc · Cited by 121
Self-citationIdiopathic Pulmonary Fibrosis: CT and Risk of Death
Ley, B., Elicker, B. M., Hartman, T. E., Ryerson, C. J., Vittinghoff, E., Ryu, J. H., Lee, J. S., Jones, K. D., Richeldi, L., King, T. E., et al. (2014) · Radiology · doi:10.1148/radiol.14130216 · Cited by 121
Self-citationNaccache, J.-M., Jouneau, S., Didier, M., Borie, R., Cachanado, M., Bourdin, A., Reynaud-Gaubert, M., Bonniaud, P., Israël-Biet, D., Prévot, G., et al. (2022) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00354-4 · Cited by 121
Inhibition of HSP27 blocks fibrosis development and EMT features by promoting Snail degradation
Wettstein, G., Bellaye, P., Kolb, M. R. J., Hammann, A., Crestani, B., Soler, P., Marchal-Sommé, J., Hazoumé, A., Gauldie, J., Günther, A., et al. (2013) · The FASEB Journal · doi:10.1096/fj.12-220053 · Cited by 121
Pulmonary fibrosis: from mechanisms to therapies
Jiang, M., Bu, W., Wang, X., Ruan, J., Shi, W., Yu, S., Huang, L., Xue, P., Tang, J., Zhao, X., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06514-2 · Cited by 120
Idiopathic pulmonary fibrosis: An update
Spagnolo, P., Sverzellati, N., Rossi, G., Cavazza, A., Tzouvelekis, A., Crestani, B., & Vancheri, C. (2015) · Annals of Medicine · doi:10.3109/07853890.2014.982165 · Cited by 120
Echocardiographic and Hemodynamic Predictors of Mortality in Idiopathic Pulmonary Fibrosis
Rivera‐Lebron, B. N., Forfia, P. R., Kreider, M. E., Lee, J. C., Holmes, J. H., & Kawut, S. M. (2013) · CHEST Journal · doi:10.1378/chest.12-2298 · Cited by 120
Saketkoo, L. A., Mittoo, S., Huscher, D., Khanna, D., Dellaripa, P. F., Distler, O., Flaherty, K. R., Frankel, S., Oddis, C. V., Denton, C. P., et al. (2014) · Thorax · doi:10.1136/thoraxjnl-2013-204202 · Cited by 120
Self-citationHistopathology of Interstitial Lung Abnormalities in the Context of Lung Nodule Resections
Miller, E. R., Putman, R. K., Vivero, M., Hung, Y. P., Araki, T., Nishino, M., Washko, G. R., Rosas, I. O., Hatabu, H., Sholl, L. M., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201708-1679le · Cited by 120
Reducing protein oxidation reverses lung fibrosis
Anathy, V., Lahue, K. G., Chapman, D. G., Chia, S. B., Casey, D. T., Aboushousha, R., van der Velden, J. L. J., Elko, E., Hoffman, S. M., McMillan, D. H., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0090-y · Cited by 120
Self-citationJohannson, K. A., Vittinghoff, E., Morisset, J., Wolters, P. J., Noth, E. M., Balmes, J. R., & Collard, H. R. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.01.015 · Cited by 120
Self-citationSong, C., He, L., Zhang, J., Ma, H., Yuan, X., Hu, G., Tao, L., Zhang, J., & Meng, J. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12898 · Cited by 120
Blood Cell Count Derived Inflammation Indexes in Patients with Idiopathic Pulmonary Fibrosis
Zinellu, A., Paliogiannis, P., Sotgiu, E., Mellino, S., Mangoni, A. A., Zinellu, E., Negri, S., Collu, C., Pintus, G., Serra, A., et al. (2020) · Lung · doi:10.1007/s00408-020-00386-7 · Cited by 120
Senotherapeutics: targeting senescence in idiopathic pulmonary fibrosis
Merkt, W., Bueno, M., Mora, A. L., & Lagares, D. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.12.008 · Cited by 119
Myofibroblasts and lung fibrosis induced by carbon nanotube exposure
Dong, J., & Ma, Q. (2016) · Particle and Fibre Toxicology · doi:10.1186/s12989-016-0172-2 · Cited by 119
Betensley, A., Sharif, R., & Karamichos, D. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm6010002 · Cited by 119
Wuyts, W. A., Kolb, M., Stowasser, S., Stansen, W., Huggins, J. T., & Raghu, G. (2016) · Lung · doi:10.1007/s00408-016-9912-1 · Cited by 119
Self-citationNavaratnam, V., Fogarty, A. W., McKeever, T., Thompson, N., Jenkins, G., Johnson, S. R., Dolan, G., Kumaran, M., Pointon, K., & Hubbard, R. B. (2014) · Thorax · doi:10.1136/thoraxjnl-2013-203740 · Cited by 119
Gunnarsson, R., Aaløkken, T. M., Molberg, Ø., Lund, M. B., Mynarek, G. K., Lexberg, Å. S., Time, K., Dhainaut, A., Bertelsen, L.-T., Palm, Ø., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-201253 · Cited by 119
Update in diagnosis and management of interstitial lung disease
Mikolasch, T., Garthwaite, H. S., & Porter, J. C. (2017) · Clinical Medicine · doi:10.7861/clinmedicine.17-2-146 · Cited by 119
Kimura, R. H., Wang, L., Shen, B., Huo, L., Tummers, W., Filipp, F. V., Guo, H. H., Haywood, T., Abou-Elkacem, L., Baratto, L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11863-w · Cited by 118
Patients With Fibrotic Interstitial Lung Disease Hospitalized for Acute Respiratory Worsening
Moua, T., Westerly, B. D., Dulohery, M. M., Daniels, C. E., Ryu, J. H., & Lim, K. G. (2016) · CHEST Journal · doi:10.1016/j.chest.2015.12.026 · Cited by 118
Self-citationSheth, J. S., Belperio, J. A., Fishbein, M. C., Kazerooni, E. A., Lagstein, A., Murray, S., Myers, J. L., Simon, R. H., Sisson, T. H., Sundaram, B., et al. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.09.028 · Cited by 118
Self-citationRaghu, G., & Meyer, K. C. (2012) · European Respiratory Journal · doi:10.1183/09031936.00211311 · Cited by 118
Self-citationAccuracy and Reliability of Internet Resources for Information on Idiopathic Pulmonary Fibrosis
Fisher, J. H., O’Connor, D., Flexman, A. M., Shapera, S., & Ryerson, C. J. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201512-2393oc · Cited by 118
Recombinant Human Thrombomodulin in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Kataoka, K., Taniguchi, H., Kondoh, Y., Nishiyama, O., Kimura, T., Matsuda, T., Yokoyama, T., Sakamoto, K., & Ando, M. (2015) · CHEST Journal · doi:10.1378/chest.14-2746 · Cited by 118
Self-citationSun, L., Zhu, M., Feng, W., Lin, Y., Jia, Y., Jin, J., & Wang, Y. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/4506303 · Cited by 118
Peripheral blood biomarkers in idiopathic pulmonary fibrosis
Vij, R., & Noth, I. (2012) · Translational Research · doi:10.1016/j.trsl.2012.01.012 · Cited by 117
Pulmonary Function and Survival in Idiopathic vs Secondary Usual Interstitial Pneumonia
Strand, M. J., Sprunger, D. B., Cosgrove, G. P., Pérez, E. R. F., Frankel, S. K., Huie, T. J., Olson, A. L., Solomon, J. J., Brown, K. K., & Swigris, J. J. (2014) · CHEST Journal · doi:10.1378/chest.13-2388 · Cited by 117
Self-citationHernández‐González, F., Lucena, C. M., Ramírez, J., Sánchez, M., Jimenez, M. J., Xaubet, A., Sellarés, J., & Agustí, C. (2015) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2015.02.001 · Cited by 117
DiBardino, D. M., Haas, A. R., Lanfranco, A. R., Litzky, L. A., Sterman, D. H., & Bessich, J. L. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201610-829oc · Cited by 117
Dhooria, S., Sehgal, I. S., Aggarwal, A. N., Behera, D., & Agarwal, R. (2016) · Respiratory Care · doi:10.4187/respcare.04488 · Cited by 117
Depression in patients with idiopathic pulmonary fibrosis
Akhtar, A. A., Ali, M. A., & Smith, R. P. (2013) · Chronic Respiratory Disease · doi:10.1177/1479972313493098 · Cited by 117
Waseda, Y., Johkoh, T., Egashira, R., Sumikawa, H., Saeki, K., Watanabe, S., Matsunuma, R., Takato, H., Ichikawa, Y., Hamaguchi, Y., et al. (2016) · European Journal of Radiology · doi:10.1016/j.ejrad.2016.05.012 · Cited by 117
Self-citationFibroblast Senescence in Idiopathic Pulmonary Fibrosis
Lin, Y., & Xu, Z. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.593283 · Cited by 116
TRIM33 prevents pulmonary fibrosis by impairing TGF-β1 signalling
Boutanquoi, P., Burgy, O., Beltramo, G., Bellaye, P., Dondaine, L., Marcion, G., Pommerolle, L., Vadel, A., Spanjaard, M., Demidov, O. N., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.01346-2019 · Cited by 116
Collard, H. R., Chen, S.-Y., Yeh, W.-S., Li, Q., Lee, Y.-C., Wang, A., & Raghu, G. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201412-553oc · Cited by 116
Self-citationPredicting Pulmonary Fibrosis Disease Course From Past Trends in Pulmonary Function
Schmidt, S. L., Tayob, N., Han, M. K., Zappala, C. J., Kervitsky, D. J., Murray, S., Wells, A. U., Brown, K. K., Martínez, F. J., & Flaherty, K. R. (2013) · CHEST Journal · doi:10.1378/chest.13-0844 · Cited by 116
Self-citationThe burden of idiopathic pulmonary fibrosis: An unmet public health need
Lee, A. S., Mira-Avendano, I. C., Ryu, J. H., & Daniels, C. E. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2014.03.015 · Cited by 116
Self-citationUse of animal models in IPF research
Carrington, R., Jordan, S., Pitchford, S. C., & Page, C. P. (2018) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2018.07.002 · Cited by 116
Hydrogel-based delivery of Il-10 improves treatment of bleomycin-induced lung fibrosis in mice
Shamskhou, E. A., Kratochvil, M. J., Orcholski, M. E., Nagy, N., Kaber, G., Steen, E. H., Balaji, S., Yuan, K., Keswani, S. G., Danielson, B. T., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.02.017 · Cited by 116
Mast Cells: A Pivotal Role in Pulmonary Fibrosis
Veerappan, A., O’Connor, N., Brazin, J. A., Reid, A. C., Jung, A., McGee, D., Summers, B. D., Branch-Elliman, D., Stiles, B. M., Worgall, S., et al. (2013) · DNA and Cell Biology · doi:10.1089/dna.2013.2005 · Cited by 116
Matrix Metalloproteinase-19 Is a Key Regulator of Lung Fibrosis in Mice and Humans
Yu, G., Kovkarova-Naumovski, E., Jara, P., Parwani, A., Kass, D., Ruiz, V., Lopez-Otín, C., Rosas, I. O., Gibson, K. F., Cabrera, S., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201202-0302oc · Cited by 116
Self-citationPulmonary Rehabilitation of Interstitial Lung Disease
Ahn, S. Y. (2022) · Annals of CardioPulmonary Rehabilitation · doi:10.53476/acpr.2022.2.1.8 · Cited by 116
Clinical course and outcome of rheumatoid arthritis-related usual interstitial pneumonia.
Song, J. W., Lee, H.-K., Lee, C. K., Chae, E. J., Jang, S. J., Colby, T. V., & Kim, D. S. (2013) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 116
Self-citationHolland, A. E., Wadell, K., & Spruit, M. A. (2013) · European Respiratory Review · doi:10.1183/09059180.00005613 · Cited by 115
IL-37 Attenuates Lung Fibrosis by Inducing Autophagy and Regulating TGF-β1 Production in Mice
Kim, M. S., Baek, A.-R., Lee, J.-H., Jang, A., Kim, D.-J., Chin, S., & Park, S. W. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801515 · Cited by 115
Self-citationNathan, S. D., du Bois, R. M., Albera, C., Bradford, W. Z., Costabel, U., Kartashov, A., Noble, P. W., Sahn, S. A., Valeyre, D., Weycker, D., et al. (2015) · Respiratory Medicine · doi:10.1016/j.rmed.2015.04.008 · Cited by 114
Self-citation
Metadata
- Authors
- Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., Lynch, D. A., Ryu, J. H., Swigris, J. J., Wells, A. U., Ancochea, J., Bouros, D., Carvalho, C., Costabel, U., Ebina, M., Hansell, D. M., Johkoh, T., Kim, D. S., King, T. E., Kondoh, Y., Myers, J., Müller, N. L., Nicholson, A. G., Richeldi, L., Selman, M., Dudden, R. F., Griss, B. S., Protzko, S. L., & Schünemann, H. J.
- Affiliations
- University of Washington (US)
- University of California, San Francisco (US)
- Mater Misericordiae University Hospital (IE)
- Ludwig-Maximilians-Universität München (DE)
- Mayo Clinic (US)
- University of Michigan (US)
- Tulane University (US)
- University of Colorado Boulder (US)
- National Jewish Health (US)
- Royal Brompton Hospital (GB)
- Hospital Universitario de La Princesa (ES)
- University Hospital of Alexandroupolis (GR)
- Universidade de São Paulo (BR)
- Tohoku University (JP)
- Royal Brompton & Harefield NHS Foundation Trust (GB)
- The University of Osaka (JP)
- University of Ulsan (KR)
- University of Modena and Reggio Emilia (IT)
- Instituto Nacional de Enfermedades Respiratorias (MX)
- ORCID
- Raghu, Ganesh
- Collard, Harold R.
- Colby, Thomas V.
- Lasky, Joseph A.
- Lynch, David A.
- Ryu, Jay H.
- Swigris, Jeffrey J.
- Wells, Athol U.
- Ancochea, Julio
- Bouros, Demosthenes
- Carvalho, Carlos
- Costabel, Ulrich
- Johkoh, Takeshi
- King, Talmadge E.
- Kondoh, Yasuhiro
- Myers, Jeffrey
- Nicholson, Andrew G.
- Richeldi, Luca
- Selman, Moisés
- Schünemann, Holger J.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-03
- Volume
- 183
- Issue
- 6
- Pages
- 788-824
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- PMC
- PMC5450933
- OpenAlex
- W2167383172
- Cited by
- 7,186
- References
- 325
- Citations by year
- 2026: 187 · 2025: 307 · 2024: 436 · 2023: 432 · 2022: 522 · 2021: 640 · 2020: 607 · 2019: 596 · 2018: 607 · 2017: 605 · 2016: 569 · 2015: 531 · 2014: 426 · 2013: 370 · 2012: 256
- FWCI
- 304.18
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Funders
- National Heart, Lung, and Blood Institute (K23HL092227)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- idiopathic pulmonary fibrosis, diagnosis, management, natural history (disease), staging, prognosis, risk factors, treatment, disease surveillance, GRADE
- MeSH terms
- Europe, Humans, International Cooperation, Japan, Latin America, Societies, Medical, United States, Evidence-Based Medicine, Idiopathic Pulmonary Fibrosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.